- D3.117 - Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice Topic Asthma Biologicals Mastocytosis and mast cells Posters from same theme - D3.03 - Trend analysis of the occurrence of allergic diseases in Polish children over the past 30 years - D3.05 - Predictive Value of Bronchodilator Reversibility and FeNO in Assessing Positive Outcomes of Bronchial Provocation Tests in Asthma Patients 000197 - Studies on the effects of various tobacco and nicotine use methods on the course and control of asthma 000248 - Evaluation of the tolerability of the administration of subcutaneous immunotherapy in a cluster schedule, in patients with rhinoconjunctivitis and/or asthma with sensitization to Olea europaea with or without sensitization to grasses 000594 - The Role of Asthma and COVID-19 in Shaping the Severity of Pediatric Mycoplasma pneumoniae Infections: A Regional Perspective from the United States 000672 - Benralizumab as treatment in a patient with Near-Fatal Asthma exacerbation
